| An unexpected N-terminal loop in PD-1 dominates binding by nivolumab. | |
| Tong,Zhou; Zhang,Hao; Wong,Gary; Song,Hao; Liu,William J.; Wang,Qihui; Zhu,Xiaodong; Chai,Yan; Qi,Jianxun; Tan,Shuguang | |
| 刊名 | Nature Communications
 |
| 2017 | |
| 卷号 | Vol.8 |
| 关键词 | CRYSTAL-STRUCTURE MONOCLONAL-ANTIBODIES CANCER-IMMUNOTHERAPY UNTREATED MELANOMA COMPLEX GLYCOSYLATION RECEPTOR LIGAND PEMBROLIZUMAB BLOCKADE |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/2201087 |
| 专题 | 安徽大学 |
| 作者单位 | 1.Northwest Univ, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian 710069, Peoples R China 2.Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100101, Peoples R China 3.Northwest Univ, Coll Life Sci, Prov Key Lab Biotechnol, Xian 710069, Peoples R China[ 10 ] Chinese Acad Sci, Inst Biophys, Lab Prot & Peptide Pharmaceut, Beijing 100101, Peoples R China[ 11 ] Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing 100101, Peoples R China 4.Beijing Combio Co Ltd, Beijing 100111, Peoples R China 5.Anhui Univ, Sch Life Sci, Hefei 230601, Peoples R China 6.Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China 7.Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Key Lab Biomed Diagnost, Suzhou 215163, Peoples R China 8.Chinese Acad Sci, Inst Microbiol, Key Lab Microbial Physiol & Metab Engn, Beijing 100101, Peoples R China 9.Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China |
| 推荐引用方式 GB/T 7714 | Tong,Zhou,Zhang,Hao,Wong,Gary,et al. An unexpected N-terminal loop in PD-1 dominates binding by nivolumab.[J]. Nature Communications,2017,Vol.8. |
| APA | Tong,Zhou.,Zhang,Hao.,Wong,Gary.,Song,Hao.,Liu,William J..,...&Tan,Shuguang.(2017).An unexpected N-terminal loop in PD-1 dominates binding by nivolumab..Nature Communications,Vol.8. |
| MLA | Tong,Zhou,et al."An unexpected N-terminal loop in PD-1 dominates binding by nivolumab.".Nature Communications Vol.8(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论